UIC given funds to develop new bioweapon antibiotics

Four million dollars in stimulus package funds will be given to researchers at the University of Illinois at Chicago to aid in the development of new antibiotics to treat anthrax, tularemia and plague. Read More

Medizone International announces positive sporicidal test results for its AsepticSure technology

Medizone International, Inc., has announced that its proprietary AsepticSure technology has continuously broken decontamination barriers in tests, establishing it as an extremely potent sporicidal technology.
Read More

Anthrax vaccine project stopped over animal rights

Oklahoma State University has put a stop to a project meant to test anthrax vaccines and treatment on baboons. Read More

Emergent BioSolutions CEO named Ernst & Young Entrepreneur of the Year

ROCKVILLE, Md. Read More

Emergent BioSolutions submits its plan for vaccine contract to FDA

ROCKVILLE, Md. Read More

Export of bioweapon technology to India to remain restricted

Consortium formed to create thermostable ricin vaccine

Positive results reported for fight against VHF

Anthrax drug maker questions approval process for drug

James Neal joins XOMA Ltd., to aid in building biodefense programs

Maryland biopharmaceutical company purchases East Baltimore bioscience center

Experimental anthrax treatment denied approval

Congressional commission says threat of bioterrorism not being addressed

New bioterror response research institute opens near Washington, D.C.

Boston biodefense complex faces legal challenges

SRI International opens research center in Virginia

Emergent BioSolutions acquires manufacturing facility from MdBio

Scientists Announce Possible Treatment for Deadly Virus

The zombies are fictional; the science is real

Michigan Security Network boosts state’s economy

  Next Entries »